Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Firebrick Pharma Ltd

FRE.AX ✗ NOT COMPLIANT ☆ Track — members

ASX · Healthcare · Pharmaceuticals ·

Australia Micro Cap Analyst: N/A

Last Close

$0.02

▲ +0.00%

Market Cap $5.43M · Vol 233.50K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$5.43M

Micro Cap

Div Yield

0.00%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

50.00

Momentum

Beta

0.89

vs Market

52W High

$0.06

63.64% below

52W Low

$0.02

13.83% above

Volume

233.50K

Avg 203.95K

P/B

8.95

Price-to-book

ROE

N/A

Return on equity

Free Float

54.56%

Public shares

Shariah Compliance8 STANDARDS

✗ Firebrick Pharma Ltd (FRE.AX) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does FRE.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+3.85%

-10.00%

-44.90%

-57.14%

YTD

-49.06%

-65.82%

-88.61%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$193.07K
Net Income	$-1,733,451.00
Revenue Growth (YoY)	-67.84%
Gross Margin	32.79%
Operating Margin	-976.65%
Net Profit Margin	-897.83%
ROE	N/A
ROA · ROIC	-124.44% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	44.43
P/B	8.95
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	285.20M

Technical Indicators

50-Day SMA	$0.02
200-Day SMA	$0.04
RSI (14)	50.00
Beta	0.89
52-Week High	$0.06
52-Week Low	$0.02

Volume Today	233.50K
Avg Daily Volume (30D)	203.95K
Relative Volume	1.14x
Volatility (10D)	176.72
Volatility (30D)	125.18
Free Float	54.56%

Analyst Consensus

N/A

Current Price $0.02

Mean Target N/A

52W Low$0.02 52W High$0.06

Current

Target

$0.02 $0.06

Current Analyst target

· 0 analysts

Identifiers

ExchangeASX

FIGIBBG0140SS6W9

ISINAU0000197352

CountryAustralia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Firebrick Pharma Limited is an Australia-based pharmaceutical company. The principal activity for the Company is the clinical development and partnering of Nasodine, a broad-spectrum antimicrobial spray for the treatment of the common cold. The Company has developed a povidone-iodine nasal spray, called Nasodine Nasal Spray and filed international trademarks and multiple patents on the product, including a formulation patent and two use patents, some of which have already been granted in the United States, Europe and Australia. The Company has also completed six clinical trials for Nasodine, including a Phase I study, three Phase II studies and two Phase III studies, which have affirmed the product’s safety and generally supported its efficacy as an antimicrobial nasal spray with utility in a range of clinical settings. Nasodine Phase II COVID-19 trail achieves primarily endpoints.